Skip to main content
Clinical Trials/NCT06578663
NCT06578663CompletedNot Applicable

Electrical Dry Needling Versus Iontophoresis in Treating Chronic Unilateral Knee Osteoarthritis

Horus University2 sites in 1 country60 target enrollmentStarted: June 1, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
60
Locations
2
Primary Endpoint
Pain intensity level measurement

Study Overview

Brief Summary

The goal of this clinical trial is to compare the effects of electrical dry needling versus glucosamine sulfate iontophoresis on pain intensity level, functional ability, and knee range of motion in chronic unilateral knee osteoarthritis patients.

Detailed Description

Knee Osteoarthritis (OA) is a chronic disease affecting 240 million people worldwide, with a higher prevalence in older adults. The disease leads to knee deformity, laxity, and ligament instability. Dry needling, a new treatment modality, uses needle electrodes to deliver an electric current to the pain-generating trigger point, improving the physiological effects and analgesic and anesthetic effects. Iontophoresis, a safer method of drug therapy, has shown to be more effective in pain reduction in knee osteoarthritic patients. The study aims to investigate the effect of electrical dry needling versus glucosamine sulfate iontophoresis on pain intensity level, knee function, and range of motion (ROM) in chronic knee OA patients. This approach aims to maximize drug bioavailability, optimize therapeutic efficacy, and minimize side effects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Masking Description

The sample will be randomly divided into three groups: A, B, and C. Group A: The control group (n=20) Group B: The study group (n=20) will receive conventional physical therapy plus electrical dry needling.

Group C: The study group (n=20) will receive conventional physical therapy plus glucosamine sulfate iontophoresis.

Eligibility Criteria

Ages
40 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The patient will be selected from the outpatient clinic of physical therapy at Horus University, New Damietta, Egypt, diagnosed with a Kellgren/Lawrence grade 2,3 radiological severity of knee osteoarthritis (OA). and referred by an orthopedist.
  • Age will range from 40 to 60 years.
  • Body mass index will range from 25 to 29.9 kg/m
  • Duration of knee pain not less than 3 months prior to study .

Exclusion Criteria

  • Patients with history of cardiac disorder with pacemaker.
  • Knee surgery.
  • Diabetes and nutritional disorder.
  • Neuromuscular and other musculoskeletal diseases.
  • Any red flags to dry needling, or conventional therapy.
  • Had received physical therapy, acupuncture, massage therapy, chiropractic, or intra-articular injections for the painful knee in the last 3 months.
  • Presented with positive neurological signs.

Outcomes

Primary Outcomes

Pain intensity level measurement

Time Frame: at baseline and after 6 weeks

The visual analog scale (VAS) is a pain rating scale .A 10-cm line that represents a continuum between the two ends of the scale-"no pain" on the left end (0 cm) of the scale and the "worst pain" on the right end of the scale (10 cm)

Functional ability measurement

Time Frame: at baseline and after 6 weeks

Knee Injury and Osteoarthritis Outcome (KOOS) Score.A 0-100 scale, with zero express extreme knee problems and 100 for no knee problems, as common in orthopedic scales.

Knee ROM measurement

Time Frame: at baseline and after 6 weeks

A digital goniometer will be used to measure active knee ROM. The subject will be supine, flexing and extending their knee to the maximum. Bony landmarks will be identified for standardization and repeatability. The goniometer will be positioned over the lateral epicondyle of the femur, with the greater trochanter for reference. Measurements will be made three times, and the average value will be analyzed. Knee ROM measurements in patients with knee OA show high reliability.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Horus University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Fayez Zehiry

lecturer assistant

Horus University

Study Sites (2)

Loading locations...

Similar Trials